(Q39506288)

12 September 2017

title

An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models (English)

1 reference

12 September 2017

1 reference

1 reference

Heather Keen

1

1 reference

12 September 2017

Bernd Pichler

2

1 reference

12 September 2017

Damaris Kukuk

3

1 reference

12 September 2017

Olivier Duchamp

4

1 reference

12 September 2017

Olivier Raguin

5

1 reference

12 September 2017

Aoife Shannon

6

1 reference

12 September 2017

Nichola Whalley

7

1 reference

12 September 2017

Vivien Jacobs

8

1 reference

12 September 2017

Juliana Bales

9

1 reference

12 September 2017

Neill Gingles

10

1 reference

12 September 2017

Sally-Ann Ricketts

11

1 reference

12 September 2017

Stephen R Wedge

12

1 reference

12 September 2017

publication date

1 June 2012

1 reference

Molecular Imaging and Biology

12 September 2017

published in

1 reference

12 September 2017

volume

14

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

355-365

1 reference

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Monitoring tumor response to therapy with 18F-FLT PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Assessing tumor response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Imaging of cell proliferation: status and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

(18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Positron-emission tomography and assessment of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

A pilot evaluation of the use of tissue microarrays for quantitation of target distribution in drug discovery pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

2-deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Using dual-tracer PET to predict the biologic behavior of human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Molecular imaging of proliferation in malignant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Biological correlates of FDG uptake in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0504-4

Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.

21 January 2018

1 reference

12 December 2020

Quantitating tumor glucose metabolism with FDG and PET

1 reference

12 December 2020

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

12 December 2020

Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts

1 reference

12 December 2020

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

1 reference

12 December 2020

Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT

1 reference

12 December 2020

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

1 reference

12 December 2020

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

1 reference

12 December 2020

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas

1 reference

12 December 2020

A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection

1 reference

12 December 2020

Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy

1 reference

12 December 2020

3'-deoxy-3'-[18F]fluorothymidine positron emission tomography is a sensitive method for imaging the response of BRAF-dependent tumors to MEK inhibition

1 reference

12 December 2020

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

1 reference

12 December 2020

18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography

1 reference

12 December 2020

Performance measurement of the microPET focus 120 scanner

1 reference

12 December 2020

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

1 reference

12 December 2020

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

12 December 2020

10.1007/S11307-011-0504-4

Identifiers

DOI

1 reference

12 September 2017

1 reference